Resumo

PIRIZ MOMBLANT, Ángel; SOLER CANO, Dayami  e  HERRERA PUENTE, Antonio. Nimotuzumab and gemcitabine in the treatment of pancreatic cancer and splenic metastases. Rev. inf. cient. [online]. 2019, vol.98, n.4, pp. 515-523.  Epub 20-Set-2019. ISSN 1028-9933.

A 69-year-old male patient presented with extrahepatic cholestasis, weight loss, asthenia and anorexia, a history of chronic pancreatitis, diabetes mellitus and arterial hypertension, who was diagnosed with adenocarcinoma of the pancreas with splenic metastases. A cholecystojejunostomy was performed with jejunum jejunostomy because the tumor was unresectable. It was included in the IIC RD-EC166 clinical trial and treated with nimotuzumab and gemcitabine. In the evolutionary studies the metastatic images that were observed before the treatment were not appreciated, which presupposes the usefulness of these drugs for their control. No references on the subject were found in the national and international literature consulted.

Palavras-chave : pancreas adenocarcinoma; nimotuzumab; gemcitabine.

        · resumo em Português | Espanhol     · texto em Espanhol     · Espanhol ( pdf )